WO1999043853A9 - Methods and apparatus for determination of length polymorphisms in dna - Google Patents
Methods and apparatus for determination of length polymorphisms in dnaInfo
- Publication number
- WO1999043853A9 WO1999043853A9 PCT/US1999/003175 US9903175W WO9943853A9 WO 1999043853 A9 WO1999043853 A9 WO 1999043853A9 US 9903175 W US9903175 W US 9903175W WO 9943853 A9 WO9943853 A9 WO 9943853A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- target
- repeat units
- hybridization
- sequence
- reporter
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 296
- 102000054765 polymorphisms of proteins Human genes 0.000 title description 8
- 238000009396 hybridization Methods 0.000 claims abstract description 183
- 239000000523 sample Substances 0.000 claims abstract description 129
- 238000012360 testing method Methods 0.000 claims abstract description 120
- 238000003556 assay Methods 0.000 claims abstract description 89
- 238000004458 analytical method Methods 0.000 claims abstract description 48
- 230000000295 complement effect Effects 0.000 claims abstract description 34
- 239000000463 material Substances 0.000 claims abstract description 26
- 230000002068 genetic effect Effects 0.000 claims abstract description 25
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 23
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 19
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 19
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 12
- 201000010099 disease Diseases 0.000 claims abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 5
- 108091035233 repetitive DNA sequence Proteins 0.000 claims abstract description 5
- 102000053632 repetitive DNA sequence Human genes 0.000 claims abstract description 5
- 108020004414 DNA Proteins 0.000 claims description 111
- 108700028369 Alleles Proteins 0.000 claims description 60
- 239000002773 nucleotide Substances 0.000 claims description 43
- 125000003729 nucleotide group Chemical group 0.000 claims description 42
- 238000001514 detection method Methods 0.000 claims description 37
- 230000003321 amplification Effects 0.000 claims description 30
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 30
- 238000002372 labelling Methods 0.000 claims description 15
- 239000000126 substance Substances 0.000 claims description 15
- 230000033228 biological regulation Effects 0.000 claims description 13
- 239000013077 target material Substances 0.000 claims description 13
- 238000012217 deletion Methods 0.000 claims description 12
- 230000037430 deletion Effects 0.000 claims description 12
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 11
- 238000003384 imaging method Methods 0.000 claims description 11
- 238000012986 modification Methods 0.000 claims description 11
- 230000004048 modification Effects 0.000 claims description 11
- 238000004925 denaturation Methods 0.000 claims description 10
- 230000036425 denaturation Effects 0.000 claims description 10
- 238000003780 insertion Methods 0.000 claims description 10
- 230000037431 insertion Effects 0.000 claims description 10
- 239000000872 buffer Substances 0.000 claims description 9
- 230000007704 transition Effects 0.000 claims description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 8
- 239000007850 fluorescent dye Substances 0.000 claims description 7
- 238000001215 fluorescent labelling Methods 0.000 claims description 7
- 238000012546 transfer Methods 0.000 claims description 7
- 230000008859 change Effects 0.000 claims description 6
- 102000053602 DNA Human genes 0.000 claims description 5
- 230000004544 DNA amplification Effects 0.000 claims description 5
- 238000003491 array Methods 0.000 claims description 5
- 230000000813 microbial effect Effects 0.000 claims description 5
- 238000012634 optical imaging Methods 0.000 claims description 5
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 4
- 238000012790 confirmation Methods 0.000 claims description 4
- 230000002255 enzymatic effect Effects 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 230000009467 reduction Effects 0.000 claims description 4
- 238000005096 rolling process Methods 0.000 claims description 4
- 238000007619 statistical method Methods 0.000 claims description 3
- 230000002103 transcriptional effect Effects 0.000 claims description 3
- 241000251468 Actinopterygii Species 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 claims description 2
- 230000001580 bacterial effect Effects 0.000 claims description 2
- 238000006073 displacement reaction Methods 0.000 claims description 2
- DLBFLQKQABVKGT-UHFFFAOYSA-L lucifer yellow dye Chemical compound [Li+].[Li+].[O-]S(=O)(=O)C1=CC(C(N(C(=O)NN)C2=O)=O)=C3C2=CC(S([O-])(=O)=O)=CC3=C1N DLBFLQKQABVKGT-UHFFFAOYSA-L 0.000 claims description 2
- 238000010791 quenching Methods 0.000 claims description 2
- 230000000171 quenching effect Effects 0.000 claims description 2
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 claims description 2
- 230000003612 virological effect Effects 0.000 claims description 2
- 230000002349 favourable effect Effects 0.000 claims 3
- 230000003750 conditioning effect Effects 0.000 claims 2
- 238000009395 breeding Methods 0.000 claims 1
- 230000001488 breeding effect Effects 0.000 claims 1
- 238000000105 evaporative light scattering detection Methods 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 108091034117 Oligonucleotide Proteins 0.000 description 35
- 238000003752 polymerase chain reaction Methods 0.000 description 17
- 108091092195 Intron Proteins 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 11
- 230000003993 interaction Effects 0.000 description 10
- 230000035772 mutation Effects 0.000 description 10
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 9
- 239000010410 layer Substances 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- 108091092878 Microsatellite Proteins 0.000 description 8
- 239000011159 matrix material Substances 0.000 description 8
- 238000007837 multiplex assay Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000007899 nucleic acid hybridization Methods 0.000 description 6
- 208000026350 Inborn Genetic disease Diseases 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 208000016361 genetic disease Diseases 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 230000027455 binding Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 238000000018 DNA microarray Methods 0.000 description 3
- 102000007330 LDL Lipoproteins Human genes 0.000 description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000009870 specific binding Effects 0.000 description 3
- -1 Bodipy Far Red Chemical compound 0.000 description 2
- 108020003215 DNA Probes Proteins 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108091092724 Noncoding DNA Proteins 0.000 description 2
- 108091005461 Nucleic proteins Proteins 0.000 description 2
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000002820 assay format Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000002801 charged material Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 238000012252 genetic analysis Methods 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000012950 reanalysis Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 108091011896 CSF1 Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000799461 Homo sapiens Thrombopoietin Proteins 0.000 description 1
- 101000694103 Homo sapiens Thyroid peroxidase Proteins 0.000 description 1
- 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 101100343714 Mus musculus Loxl4 gene Proteins 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 206010034016 Paronychia Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000009585 enzyme analysis Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000008826 genomic mutation Effects 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000013383 initial experiment Methods 0.000 description 1
- 238000005305 interferometry Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229910021426 porous silicon Inorganic materials 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 125000006853 reporter group Chemical group 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000028016 temperature homeostasis Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000002676 xenobiotic agent Substances 0.000 description 1
- 230000002034 xenobiotic effect Effects 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L29/00—Semiconductor devices adapted for rectifying, amplifying, oscillating or switching, or capacitors or resistors with at least one potential-jump barrier or surface barrier, e.g. PN junction depletion layer or carrier concentration layer; Details of semiconductor bodies or of electrodes thereof ; Multistep manufacturing processes therefor
- H01L29/66—Types of semiconductor device ; Multistep manufacturing processes therefor
- H01L29/66007—Multistep manufacturing processes
- H01L29/66075—Multistep manufacturing processes of devices having semiconductor bodies comprising group 14 or group 13/15 materials
- H01L29/66227—Multistep manufacturing processes of devices having semiconductor bodies comprising group 14 or group 13/15 materials the devices being controllable only by the electric current supplied or the electric potential applied, to an electrode which does not carry the current to be rectified, amplified or switched, e.g. three-terminal devices
- H01L29/66409—Unipolar field-effect transistors
- H01L29/66477—Unipolar field-effect transistors with an insulated gate, i.e. MISFET
- H01L29/6656—Unipolar field-effect transistors with an insulated gate, i.e. MISFET using multiple spacer layers, e.g. multiple sidewall spacers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6825—Nucleic acid detection involving sensors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00653—Making arrays on substantially continuous surfaces the compounds being bound to electrodes embedded in or on the solid supports
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00659—Two-dimensional arrays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Definitions
- the methods and apparatus of these inventions relate to systems for genetic identification for disease state identification. More particularly, the methods and apparatus relate to systems for the detection of repeat unit states, such as the number of short tandem repeat units for the identification of individuals such as in a forensic or paternity sense, or for determination of disease states, such as for clonal tumor detection.
- repeat unit states such as the number of short tandem repeat units for the identification of individuals such as in a forensic or paternity sense
- determination of disease states such as for clonal tumor detection.
- Molecular biology comprises a wide variety of techniques for the analysis of nucleic acid and protein. Many of these techniques and procedures form the basis of clinical diagnostic assays and tests. These techniques include nucleic acid hybridization analysis, restriction enzyme analysis, genetic sequence analysis, and the separation and purification of nucleic acids and proteins (See, e.g., J. Sambrook, E. F. Fritsch, and T. Maniatis, Molecular Cloning: A Laboratory Manual, 2 Ed., Cold spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989).
- the complete process for carrying out a DNA hybridization analysis for a genetic or infectious disease is very involved. Broadly speaking, the complete process may be divided into a number of steps and substeps.
- the first step involves obtaining the sample (blood or tissue). Depending on the type of sample, various pre- treatments would be carried out.
- the second step involves disrupting or lysing the cells, which then release the crude DNA material along with other cellular constituents. Generally, several sub-steps are necessary to remove cell debris and to purify further the crude DNA. At this point several options exist for further processing and analysis. One option involves denaturing the purified sample DNA and carrying out a direct hybridization analysis in one of many formats (dot blot, microbead, microplate, etc.).
- a second option called Southern blot hybridization, in volves cleaving the DNA with restriction enzymes, separating the DNA fragments on an electrophoretic gel, blotting to a membrane filter, and then hybridizing the blot with specific DNA probe sequences.
- This procedure effectively reduces the complexity of the genomic DNA sample, and thereby helps to improve the hybridization specificity and sensitivity.
- This procedure is long and arduous.
- a third option is to carry out an amplification procedure such as polymerase chain reaction (PCR), strand displacement amplification or other method. These procedures amplify (increase) the number of target DNA sequences relative to non-target sequences. Amplification of target DNA helps to overcome problems related to complexity and sensitivity in genomic DNA analysis.
- Nucleic acid hybridization analysis generally involves the detection of a very small number of specific target nucleic acids (DNA or RNA) with an excess of probe DNA, among a relatively large amount of complex non-target nucleic acids.
- the substeps of DNA complexity reduction in sample preparation have been utilized to help detect low copy numbers (i.e. 10,000 to 100,000) of nucleic acid targets.
- DNA complexity is overcome to some degree by amplification of target nucleic acid sequences using polymerase chain reaction (PCR) and other methods. (See, M.A.
- hybridization results in an enormous number of target nucleic acid sequences that improves the subsequent direct probe hybridization step.
- the actual hybridization reaction represents one of the most important and central steps in the whole process.
- the hybridization step involves placing the prepared DNA sample in contact with a specific reporter probe, at a set of optimal conditions for hybridization to occur to the target DNA sequence.
- Hybridization may be performed in any one of a number of formats. For example, multiple sample nucleic acid hybrid-ization analysis has been conducted on a variety of filter and solid support formats (See G. A.
- the micro-formatted hybridization can be used to carry out "sequencing by hybridization” (SBH) (see M. Barinaga, 253 Science, pp. 1489, 1991; W. Bains, 10 Bio/Technology, pp. 757-758, 1992).
- SBH makes use of all possible n-nucleotide oligomers (n-mers) to identify n-mers in an unknown DNA sample, which are subsequently aligned by algorithm analysis to produce the DNA sequence (R. Drmanac and R. Crkvenjakov, Yugoslav Patent Application #570/87, 1987; R. Drmanac et al., 4 Genomics, 114, 1989; Strezoska et al., 88 Proc. Natl. Acad. Sci. USA 10089, 1992; and R. Drmanac and R. B. Crkvenjakov, U.S. Patent #5,202,231, April 13, 1993).
- the first format involves creating an array of all possible n-mers on a support, which is then hybridized with the target sequence.
- the second format involves attaching the target sequence to a support, which is sequentially probed with all possible n-mers. Both formats have the fundamental problems of direct probe hybridizations and additional difficulties related to multiplex hybridizations.
- Southern identified a known single point mutation using PCR amplified genomic DNA.
- Southern also described a method for synthesizing an array of oligonucleotides on a solid support for SBH.
- Southern did not address how to achieve optimal stringency condition for each oligonucleotide on an array.
- Drmanac et al. 260 Science 1649-1652, 1993, used the second format to sequence several short (116 bp) DNA sequences.
- Target D As were attached to membrane supports ("dot blot" format). Each filter was sequentially hybridized with 272 labeled 10-mer and 11-mer oligonucleotides.
- a wide range of stringency condition was used to achieve specific hybridization for each n-mer probe; washing times varied from 5 minutes to overnight, and temperatures from 0%C to 16%C.
- fluorophore, enzyme, radioisotope, etc. fluorophore, enzyme, radioisotope, etc.
- STR's Short tandem repeats
- STR's Short tandem repeats
- researchers have been identified as a useful tool in both forensics and in other areas (paternity testing, tumor detection, D. Sidransky, genetic disease, animal breeding). Indeed, the United States Federal Bureau of Investigation has announced that it is considering the use of short tandem repeat sequences for forensic purposes. (Dr. Bruce Budowle, DNA Forensics, Science, Evidence and Future Prospects, McLean, VA. Nov. 1997).
- Tautz discloses a method which includes these steps of addition of at least one primer pair onto the DNA that is to be analyzed, wherein one of the molecules of the primer pair is substantially complementary to the complementary strands of the 5' respectively 3' flank of a simple or cryptically simple DNA sequence and wherein the addition takes place within orientation that is such that the synthesis products obtained from a primer controlled polymerization reaction with one of the two primers can be used, following denaturation, as matrices for the addition of the other primer, performing a primer-controlled polymerization reaction and separating, such as by normal gel electrophoresis the products and analyzing the polymerase chain reaction products.
- Caskey et al. at the Baylor College of Medicine also detected polymorphisms in a short tandem repeat by performing DNA profiling assays.
- U.S. Patent No. 5,364,759, issued November 15, 1994, entitled "DNA Typing With Short Tandem Repeat Polymorphisms and Identification of Polymorphic Short Tandem Repeats” discloses a method including steps of extracting DNA from a sample to be tested, amplifying the extracted DNA and identifying the amplified extension products for each different sequence. Caskey required that each different sequence be differentially labeled. A physical separation was performed utilizing electrophoresis.
- the sequence of the capture probe differs at least two test sites.
- the hybridization complex assays are then monitored to determine concordance and discordance among the hybridization complex assays at the test sites as determined at least in part by hybridization stability.
- the nature of the repeat units in the target sequence may be determined based upon the concordant/discordant determination coupled with knowledge of the probes located in the hybridization complex at that site.
- electronically aided hybridization or concordance and discordance determination are utilized in the process.
- electronic stringent conditions may be utilized, preferably along with other stringency affecting conditions, to aid in the hybridization. This technique is particularly advantageous to reduce or eliminate slippage hybridization among repeat units, and to promote more effective hybridization.
- electronic stringency conditions may be varied during the hybridization complex stability determination so as to more accurately or quickly determine the state of concordance or discordance.
- a method for the determination of the nature of the repeat units in a genetic target by providing a bioelectronic device including a set of probes arrayed at a set of test sites, the probes having a first unique flanking sequence, a second unique flanking sequence, and an intervening repeat unit series having variable numbers of repeat units.
- the target is hybridized with the set of probes at the set of test sites, under electronic stringency hybridization conditions, and the concordance/discordance at the test sites is then determined.
- the concordance/discordance is determined at least in part through the use of electronic hybridization stability determinations.
- the concordant test site indicates which probe includes the number of repeat units identical to that in the target.
- electronic stringency control is utilized only during the concordance/discordance determination.
- a platform is provided for the identification of target alleles which includes probes selected from the group consisting of (i) a probe having a first unique flanking sequence, an intervening repeat region and a second unique flanking sequence, and (ii) a sandwich assay comprising a capture probe having a first unique flanking sequence and 0,1,2... repeat units and a reporter probe having 0,1,2... repeat units in sequence with a second unique flanking sequence.
- the target is hybridized with the probes, preferably under electronic stringent conditions so as to aid in proper indexing, or alternatively, utilizing electronic stringency conditions during subsequent steps, or using electronic stringency both during hybridization and at later steps, thereafter determining concordance and discordance at the test sites as determined at least in part by hybridization stability.
- the location of the concordant test site represents the nature of the target sequence repeat units by the number of repeat units present in the target, and that in turn is based upon the knowledge of the probes located at that test site.
- the particular probes associated with a given physical test site typically will be known in terms of their sequence, especially including the number of repeat units, and the physical position of those test sites results in a knowledge for the concordant sites of the nature of the target, especially the number of repeat units.
- the number of repeat units in the target equals the sum of the number of repeat units in the capture probe and the number of repeat units in the reporter probe.
- microvariants may include one or more deletions, insertions, transitions and/or transversions.
- Our method is an hybridization technique and is quite adept at reliably detecting single nucleotide polymorphisms as described above. Additionally, by designing specific capture and reporter oligonucleotides these assays can be done on the same platform used to discriminate the nature of STR alleles by repeat unit number.
- the general strategy of designing capture oligos for microvariant analysis is the same as it is for integral- repeat units, however reporter oligos may differ in that they may or may not contain unique flanking sequence. The condition of effectively determining concordance by maximizing the hybridization complex stability remains since oligo design parameters which yield base stacking (as described above) are still followed..
- one mode of concordance may be that in which there is a complementary match of bases in the hybridization complex including the capture, reporter and target in the sandwich assay format.
- the use of juxtaposed terminal nucleotides of the reporter and capture may be utilized, wherein their contiguous nature permits interaction, such as base stacking.
- the juxtaposed terminal nucleotide identities may be selected, as allowed by the existing repeat unit or otherwise relevant sequence, so as to increase the energy difference between concordance and discordance.
- the terminal nucleotides may be modified to increase base stacking effects, such as with the addition of propynyl groups, methyl groups or cholesterol groups.
- ligation techniques may be utilized, such as enzyme ligation or chemical ligation, so as to increase the energy difference between a concordant and discordant site.
- Discordance may be manifested in various ways, such as in the sandwich assay format wherein a gap or overlap exists, or in the loop out method where a loop out exists. Further, discordance may exist in the repeat region where there is a base variation, such as a deletion, insertion, transition and/or transversion. In distinguishing concordant and discordant test sites, the distinction is preferably drawn in part based on hybridization stability. Hybridization stability may be influenced by numerous factors, including thermoregulation, chemical regulation, as well as electronic stringency control, either alone or in combination with the other listed factors. Through the use of electronic stringency conditions, in either or both of the target hybridization step or the reporter oligonucleotide stringency step, rapid completion of the process may be achieved.
- Electronic stringency hybridization of the target is one distinctive aspect of this method since it is amenable with double stranded DNA and results in rapid and precise hybridization of the target to the capture. This is desirable to achieve properly indexed hybridization of the target DNA to attain the maximum number of molecules at a test site with an accurate hybridization complex.
- the initial hybridization step may be completed in ten minutes or less, more preferably five minutes or less, and most preferably one minute or less.
- the analytical process may be completed in less than half an hour.
- the complex is labeled.
- the step of determining concordance and discordance there is a detection of the amount of labeled hybridization complex at the test site or a portion thereof.
- Labeling may be of the target, capture or reporter. Various labeling may be by fluorescent labeling, colormetric labeling or chemiluminescent labeling.
- detection may be via energy transfer between molecules in the hybridization complex.
- the detection may be via fluorescence perturbation analysis.
- the detection may be via conductivity differences between concordant and discordant sites.
- a redundant assay may be conveniently performed.
- a serial redundant assay may be utilized, such as where after an initial hybridization complex assay is performed, the stringency conditions are increased so as to effect denaturation, thereby removing the reporter from the first hybridization complex assay.
- a second reporter may then be hybridized to the remaining complex target and capture probe, wherein the second reporter includes a number of repeat units which differs from the number or type of repeat units in the first reporter.
- Yet another redundant assay may be performed wherein multiple, e.g., two or more, independent sets of assays exist.
- a first reporter is hybridized to a first set of assays
- a second reporter is hybridized to a second set of assays, wherein the number of repeat units in the first reporter differs from the number or nature of repeat units in the second reporter. Determination of concordance/discordance at the test site of the arrays, when coupled with the knowledge of the probes located as those test sites, provides two complexes from the hybridization assays for confirmation of the target repeat number or nature.
- the systems and methods of these inventions are particularly useful for determining the nature of complex samples, such as heterozygous samples, and mixed samples such as those from multiple sources or donors.
- the methods and systems of these inventions may be utilized for a broad array of applications. Among them include identification, such as for paternity testing or for other forensic use. Yet another application is in disease diagnostics, such as for the identification of the existence of a clonal tumor, where the tumor includes repeat units of a nature or number different than the patient's undiseased genetic state.
- FIG. 1 A is a cross sectional view of one embodiment of an active matrix device useful in accordance with the methods of this invention.
- FIG. IB is a perspective view of an active array device useful with the methods of this invention.
- FIG. 2 is a symbolic drawing of the components of a multiplex assay, including a target, a reporter and a capture sequence.
- FIGS. 3 A, 3B and 3C are diagrammatic sketches of the multiplex assay including a target, reporter and capture sequence in which there is existing a gap, overlap and match, respectively.
- FIGS. 4A, 4B and 4C show a detailed sequence listing for a multiplex assay of the
- TH01 locus evidencing a gap, an overlap and a match, respectively, corresponding to the diagrammatic representations of FIGS. 3 A, 3B and 3C.
- FIGS. 5 A - 5G depict a diagrammatic view of a sequence of multiplex assays showing a target with eight repeat units, a reporter with a single repeat unit and capture sequences including from four to ten repeat units, in FIGS. 5 A - 5G, respectively.
- FIG. 6 shows a plan view of an array of test sites for a sandwich assay, with the concordant test site depicted as shaded to represent the presence of hybridization complex.
- FIGS. 7 A - 7G show a diagrammatic view of a multiplex discrimination system, including a target having eight base repeat units, a reporter having two base repeat units, and a series of capture sequences including from four to ten repeat units in FIGS. 7 A - 7G, respectively.
- FIG. 8 shows a plan view of an array of test sites for a redundant assay with the concordant test depicted as shaded to represent the presence of hybridization complex.
- FIG. 9A shows a diagrammatic view of a target and hybridized reporter in a concordant condition.
- FIG. 9B shows a target and reporter in a discordant condition, namely in a loop condition.
- FIGS. 10A - 10G depict multiplex discrimination in a loop out system wherein a target includes seven repeat units and the reporters include from five to eleven repeat units in FIGS. 10A - 10G, respectively.
- FIG. 11 is a graph of fluorescence (MFI) as a function of capture oligo repeat unit- number in the identification of THOl target DNA alleles by the sandwich hybridization method.
- MFI fluorescence
- FIG. 12 is a graph of normalized fluorescence as a function of the number of repeat units in the capture sequence, where the reporter includes one repeat unit (left-hand side) and includes zero repeat units (right-hand side) showing a redundant reporter system for the THOl locus.
- FIG. 13 is a chart showing the specific olignucleotides utilized for capture sequences, reporter sequences and the target alleles in the THOl locus.
- FIG. 14 is a graph of discrimination ratios as a function of G-A stacking compared to
- T-A stacking in the paired left, right or graphs, respectively, for an eight x versus seven x discrimination (left-hand bars) and for a fifteen x versus fourteen x discrimination (right- hands bars) showing discrimination of targets by G-A and T-A stacking.
- FIG. 15 is a graph of discrimination ratio showing four couplets for chip one through chip four, respectively, showing maximum discrimination ratios utilizing a ten mer reporter
- FIG. 16 is a graph of normalized fluorescence intensity as a function of capture oligo, in a heteroxygeous TPOX locus.
- FIG. 17 is a table of the nucleotide sequences for the TPOX capture oligonucleotides, reporter oligonucleotides and target allele for the TPOX locus.
- FIG. 18 is a graph of fluorescence intensity (MFI/sec) as a function of number of capture repeat units for hybridization discrimination of CSF1PON alleles.
- FIG. 19 is a table of the capture oligonucleotides, reporter oligonucleotides and target alleles in the CSF1PO alleles.
- FIG. 20 is a graph of normalized intensity as a function of repeat unit number in the capture sequence in a THOl /TPOX multiplex analysis.
- FIG. 21 is a graph of relative fluorescence as a function of repeat unit number in the capture oligonucleotide in a system for the identification of repeat unit alleles in double stranded polymers chain reaction (PCR) amplified DNA including the target THOl locus.
- FIGS. 22 A, 22B and 22C are graphs of the fluorescence (MFI) as a function of capture oligonucleotide having a gap (leftmost bar in triplet), match (center bar in triplet) or overlap (right bar in triplet) for the initial signal, for the signal after three minutes of denaturation and for the signal after ten minutes of denaturation for FIGS. 22 A through 22C, respectively.
- MFI fluorescence
- FIG. 23 is a table showing the discrimination of match from mismatch/gap and mismatch/overlap for various combinations.
- FIG. 24 is a graph of percentage fluorescence as a function of number of repeat units in the capture sequence for a determination of the nature and number of repeat units in allelic identity of target DNA utilizing the loop out analysis.
- FIGS. 25 A, 25B and 25C show a detailed sequence listing for a multiplex THOl microvariant assay, evidencing a gap, an overlap and a match, respectively.
- FIG. 26 is a graph of fluorescence intensity (MFI) as a function of capture oligonucleotide number or nature for the detection of the microvariant allele THOl 9.3.
- MFI fluorescence intensity
- Figs. 1 A and IB illustrate a simplified version of the active programmable electronic matrix hybridization system for use with this invention.
- a substrate 10 supports a matrix or array of electronically addressable microlocations 12.
- the various microlocations in Fig. 1 A have been labeled 12 A, 12B, 12C and 12D.
- a permeation layer 14 is disposed above the individual electrodes 12. The permeation layer permits transport of relatively small charged entities through it, but limits the mobility of large charged entities, such as DNA, to keep the large charged entities from easily contacting the electrodes 12 directly during the duration of the test.
- the permeation layer 14 reduces the electrochemical degradation which would occur in the DNA by direct contact with the electrodes 12, possibility due, in part, to extreme pH resulting from the electrolytic reaction.
- Attachment regions 16 are disposed upon the permeation layer 14 and provide for specific binding sites for target materials.
- the attachment regions 16 have been labeled 16A, 16B, 16C and 16D to correspond with the identification of the electrodes 12A-D, respectively.
- reservoir 18 comprises that space above the attachment regions 16 that contains the desired, as well as undesired, materials for detection, analysis or use.
- Charged entities 20, such as charged DNA are located within the reservoir 18.
- the active, programmable, matrix system comprises a method for transporting the charged material 20 to any of the specific microlocations 12.
- a microlocation 12 When activated, a microlocation 12 generates the free field electrophoretic transport of any charged functionalized specific binding entity 20 towards the electrode 12. For example, if the electrode 12A were made positive and the electrode 12D negative, electrophoretic lines of force 22 would run between the electrodes 12A and 12D. The lines of electrophoretic force 22 cause transport of charged binding entities 20 that have a net negative charge toward the positive electrode 12 A.
- STR short tandem repeat
- a repeat unit or repeat units typically refers to individual simple sequence motifs which are repeated in a short tandem repeat. Repeat units may be, by way of examples, complete repeat units which contain identically repeating simple sequence motifs, or may be partial repeat units, such as where there is some difference between repeat units, such as in the existence of microvariants between repeat units.
- a concordant test site is taken to be a test site exhibiting a relative or local maxima of hybridization complex stability.
- a concordant test site may be one wherein the number of repeat units in the target is equal to the number of repeat units in a capture plus the number of repeat units in a reporter probe for a multiple system, or wherein the number of repeat units in the target equals the number of repeat units in a probe.
- a concordant test site may be manifested by a site where the repeat units in the target are substantially similar to the nature of the repeat units in the capture plus probe, or single probe, as appropriate.
- a discordant site is a site exhibiting a relatively lower level of hybridization complex stability relative to at least one other site. Examples of test sites which typically would be termed discordant would be those where there exists a gap, overlap, point mutation (e.g., single base variation such as deletion, insertion, transition and transversion), point mutations plus overlap, point mutations plus gap, single nucleotide - variants or other microvariants.
- a hybridization complex assay in a multiplex system typically will include a target, a capture and a reporter.
- a hybridization complex assay in a loopout application includes at least typically a target and a probe.
- An array as used herein typically refers to multiple test sites, minimally two or more test sites. The typical number of test sites will be one for each allele of the locus. The number of loci required for a test will vary depending on the application, with generally one for genetic disease analysis, one to five for tumor detection six, eight, nine thirteen or more for paternity testing and forensics. The physical positioning of the test sites relative to one another may be in any convenient configuration, where linear or in an arrangement of rows and columns.
- FIG. 2 shows a symbolic drawing of the components of a multiplex assay.
- a target 30 includes a first unique flanking region 32, a second unique flanking region 34 and one or more repeat units 36 disposed between the first unique flanking region 32 and the second unique flanking region 34.
- the target 30 may be a single or double stranded nucleic acid from specific loci, such as THOl .
- a reporter 40 includes at least a unique sequence region 42, and optionally includes one or more repeat units 44 disposed at the terminal end of the unique sequence region 42.
- the reporter 40 may have no repeat units 44, or may include one or more repeat units 44. If the reporter 40 is to be labeled, a label 46 is associated therewith.
- the unique sequence region 42 of the reporter 40 is complementary to the second unique flanking region 34 of the target 30.
- the capture 50 includes a capture unique sequence region 52 and one or more repeat units 54 which are adjoined to the terminal end of the capture unique sequence region 52. If the capture 50 is to be attached to a solid support or other anchoring medium, an attachment element 56, such as biotin may be utilized.
- Figs. 3 A, 3B and 3C are diagrammatic sketches of the multiplex assay including a target, reporter and capture sequence in which there exists a gap, overlap and match, respectively. For simplicity, the numbering of Fig. 2 will be adopted here for corresponding structures. In Fig. 3A, a gap condition exists. Broadly, the target 30 is hybridized to the reporter 40 and to the capture 50.
- the second unique flanking region 34 is hybridized to the complementary strand comprising the unique sequence region 42 of the reporter 40.
- the first unique flanking region 32 of the target 30 is hybridized to the complementary capture unique sequence region 52 of the capture 50.
- the target 30 includes - eight repeat units 36 in this example.
- Fig. 3A depicts a gap region 56, which results from the capture 50 having six repeat units 54 and the reporter 40 having one repeat unit 44.
- the total number of repeat units 44, 54 in the reporter plus capture is seven, which is one less than the total number of repeat units 36 in the target 30.
- Fig. 3B an overlap condition is shown.
- the capture includes eight repeat units 34, and the reporter 40 still includes a single repeat unit 44.
- the total number of repeat units 34, 44 between the capture 50 and reporter 40 is nine, exceeding the number of repeat units 36 in the target 30, whereby one repeat unit is overlapped, here shown to be the repeat unit 44 associated with the reporter 40.
- Fig. 3C shows a match between the target 30 and the reporter 40 plus capture 50.
- FIG. 4A, 4B and 4C show one example of specific nucleotide sequences corresponding to the examples of Figs. 3A, 3B and 3C. Note that the left to right orientation of Figs. 3A, 3B and 3C is reversed left to right for Figs. 4A, 4B and 4C.
- Fig. 4A shows a gap condition wherein the gap 56 is disposed between the repeat unit 44 of the reporter 40 and the terminal repeat unit (5'CATT3') adjacent the gap 56 of the capture 50.
- the base repeat unit 36 of the target 30 is 5'AATG3', and accordingly, its complement base sequence is 5'CATT3' 44, 54.
- Figs. 4A, 4B and 4C shows a gap condition wherein the gap 56 is disposed between the repeat unit 44 of the reporter 40 and the terminal repeat unit (5'CATT3') adjacent the gap 56 of the capture 50.
- the base repeat unit 36 of the target 30 is 5'AATG3', and accordingly, its complement base sequence is 5'
- the nucleotides of the base repeat unit are shown in capital letters. This is done to designate those units in distinction to the nucleotides forming the first unique flanking region 32 and second unique flanking region 34 of the target 30 as well as the unique region sequence 42 of the reporter 40 and the capture unique sequence region 52 of the capture 50.
- the nucleotides in the hybridized strands are paired, namely A-T and G-C pairs are complementary.
- Fig. 4B shows a mismatch with an overlap of one repeat unit. Specifically, the base repeat unit 44 comprising the series 5'CATT3' is displaced from a hybridized condition with the base unit 36 adjacent the second unique flanking region 34 of the target 30.
- the 5' terminal nucleotide (designated "c") of the unique sequence region 42 of the reporter 40 is shown as being slightly displaced from complete hybridization with the complementary "g" terminal nucleotide of the second unique flanking region 34 of the target 30.
- This depiction is optional, and may also include the condition in which the terminal nucleotide of the unique sequence region 42 is in a hybridized condition with the terminal nucleotide of the second unique flanking region 34 of the target 30.
- Fig. 4C shows a match condition, where in this example, the nature of the repeat region, that is both number of repeat units partial and whole, and the complementarity of the sequence match., In the matched condition of Fig.
- the 5' terminal nucleotide "C" of the repeat unit 44 of the reporter 40 is adjacent and contiguous with the 3' terminal nucleotide "T" of the base repeat unit 54 of the capture 50, permitting base stacking between the 5' "C” of the repeat unit 44 of the reporter 40 and the 3' "T” of the base repeat unit 54 of the capture oligonucleotide 50.
- the two base stacked nucleotides are underlined in Fig. 4C.
- the hybridization complex may anchored via the capture oligo 50 which would contain the appropriate attachment chemistry, preferably biotin at its 5' terminus.
- the hybridization complex would be labeled via the reporter oligo 40 with an appropriate molecule, preferably a chromophore at it's 3' end.
- Partial repeat units also known as microvariants or cryptically simple sequence, may be comprised of single nucleotide divergences from the most common repeat unit sequence. These divergences may consist of insertions, deletions, transition or transversion polymorphisms of the simple repeat sequence.
- Figure 25 demonstrates how this invention detects the presence of a common microvariant THOl 9.3.
- Two new entities are presented here: a microvariant target sequence
- Fig. 25 shows the relationship of the DNA subsequences when the nature of the target allele is nine whole repeat units and one partial repeat, resulting in a matched concordancy. Elements which have been discussed before in Fig. 4A-4C have retained their numerical appellation, and novel features have been labeled with new numbers.. Therefore the target sequence 70 is made up of a first unique sequence 34, integral repeat sequence 36, second unique flanking sequence 32 and presents partial repeat sequence 71.
- the capture sequence 50 is identical to that described in Fig. 4A, with the exception that it has only three repeat units 54.
- the microvariant reporter 80 is similar to reporter 40 in that it has repeat sequence 44 but differs by a lack of unique flanking sequence and by the inclusion of sequence 81 which is complementary to the target 70 partial repeat unit 71.
- the reporter 80 stability is enhanced by two features. First it is complementary only to the microvariant region and second, it will base stack and therefore attain concordancy or a local maxima of stability only at the site which contains the 3ru capture oligo.
- One practiced in the art will realize how to apply this invention to microvariant sequences which differ from the THOl 9.3 sequence.
- Figure 26 demonstrates the effectiveness of this method. Selection of the adjacent or proximal nucleotides so as to increase the energy difference between concordant and discordant test sites is advantageously employed.
- Figs. 5A-5G depict a diagrammatic representation of a multiplex system.
- the hybridization complex used in this system is sometimes termed a sandwich assay.
- the numbering adopted corresponds to that utilized with Fig. 2, Figs. 3A, 3B and 3C and Figs. 4A, 4B and 4C.
- a target 30 has a unique flanking region 32 and a second unique flanking region 34, with an intervening set of repeat units 36.
- the number of repeat units 36 is 8.
- the reporter 40 includes a unique sequence region 42 which is complementary to the second unique flanking region 34, and includes in this example one repeat unit 44 at the terminal end of the reporter.
- the capture 50 includes a capture unique sequence region 52 and, in this example, multiple repeat units 54 at the terminal end of the capture 50.
- the capture unique sequence region 52 is complementary to the first unique flanking region 32.
- Fig. 5 A shows a capture 50 with 4 repeat units 54. Since the sum of the number of- repeat units 54 in the capture 50 plus the number of repeat units 44 in the reporter 40 (4+1) is less than the number of repeat units 36 in the target 30 (eight) a gap 56 exists.
- the gap as shown in Fig. 5 A is substantially of the length of 3 repeat units 36, 44, 54.
- the number of repeat units 54 in the capture 50 is sometimes denominated an "N capture", where N equals the number of base repeat units 54 in the capture 50 plus the number of base repeat units 44 in the reporter 40.
- N capture where N equals the number of base repeat units 54 in the capture 50 plus the number of base repeat units 44 in the reporter 40.
- a match exists with a N capture where N equals the number of repeat units 36 in the target 30.
- a capture 50 having 7 repeat units 54 may be also denominated an "8 capture” since the capture 50 having 7 repeat units 54 when used with these selected reporter 40 having a single repeat unit 44 provides a match in that the total number of repeat units 44, 54 equals the number of repeat units 36 in the target.
- naming or number conventions may be utilized to accurately describe the underlying arrangements, and it is those underlying arrangements which comprise the inventions herein, and not the naming or numbering conventions adopted.
- Fig. 5B shows a capture 50 having 5 repeat units 54, wherein a gap 56 of the length of substantially 2 repeat units 36, 44, 54 exists.
- Fig. 5C shows a capture 50 having 6 repeat units 54, wherein a gap 56 of substantially the length of a single repeat unit 36, 44, 56 exists.
- Fig. 5D shows a match condition with a capture 50 having 7 repeat units 54 and a reporter 40 having a single repeat unit 44 equals the number of repeat units 36 in the target 30.
- Figs. 5E, 5F and 5G show an overlap condition.
- Fig. 5E shows a capture 50 with 8 repeat units 54.
- the reporter 40 repeat unit 44 is shown as being in a substantially non-hybridized condition with the target 30.
- Fig. 5F shows a capture 50 with 9 repeat units 54, wherein a terminal repeat unit 58 of the capture 50 and the repeat unit 44 of the reporter 40 are both in a substantially non-hybridized condition with respect to the target 30.
- Fig. 5G shows a capture 50 having 10 repeat units 54, such that the two terminal repeat units 58 of the capture 50 and the repeat unit 44 of the reporter 40 are in a substantially non-hybridized relationship with the target 30.
- Fig. 5E shows a capture 50 with 8 repeat units 54.
- the reporter 40 repeat unit 44 is shown as being in a substantially non-hybridized condition with the target 30.
- Fig. 5F shows a capture 50 with 9 repeat units 54, wherein a terminal repeat
- FIG. 6 shows a plan view of an array of test sites for use in a multiplex assay, such as a sandwich assay.
- the concordant test site is determined to be at the site containing the 7 repeat unit capture.
- This figure depicts an assay done with a 1 repeat unit reporter, therefore one can determine that the target must contain 8 repeat units since at the concordant site, the number of repeat units in the capture (7) plus the number of repeat units in the reporter (1) equals 8.
- the depiction relates to the diagram of Fig. 5 in that it shows the results attained in the analysis of a DNA sample containing an eight repeat unit target with a one repeat unit reporter.
- Figs. 7A through 7G are diagrammatic depictions of a multiplex system, such as a sandwich assay, in which the reporter includes two repeat units. This is in distinction to the assay of Figs. 5 A-G wherein the reporter included a single repeat unit. Again, for expository convenience, the numbering of earlier figures will be adopted to the extent of similarity.
- Fig. 7 A shows a target 30 having a first unique flanking region 32 and a second unique flanking region 34.
- the reporter 40 includes a unique sequence region 42 and, in this example, two repeat units 44.
- the capture sequence 50 includes a capture unique sequence region 52 and 4 repeat units 54.
- the capture 50 may be referred to as a "5 capture", reflecting the terminology utilized in connection with the assay of Figs. 5A-5G, namely those in which a reporter 40 having a single repeat unit 44 is utilized.
- Fig. 7B shows a multiplex system wherein the capture 50 includes 5 base units 54.
- Each of the examples of Fig. 7A and 7B include a gap 56.
- Fig. 7C depicts the concordant test site in that the match condition exists. Note that the effective location of the concordant test site has shifted from Fig. 5D to
- a reporter 40 being one base unit 44 shorter or longer will shift the physical location of the concordant test site, such as in Fig. 6 from test site 26D to 26C when going from a reporter of one repeat unit 44 to a reporter 40 having two repeat units 44.
- Figs. 7B-7G show an overlap condition.
- Fig. 7D one repeat unit 44 of the reporter
- Fig. 7E shows an overlap condition wherein repeat units 60 are in a non-hybridized condition with the target 30.
- Fig. 7F and 7G also include mismatch arrangements including overlap wherein multiple repeat units 60 are in a non-hybridized condition with the target 30.
- the mismatch repeat units may either be those from the reporter 30 or from the capture 50, or a combination of both.
- Fig. 8 shows a plan view of an array of test sites for use in a multiplex assay, such as a sandwich assay. The concordant test site is determined to be at the site containing the 6 repeat unit capture.
- This assay depicts an assay done with a 2 repeat unit reporter, therefore one can determine that the target must contain 8 repeat units since at the concordant site, the number of repeat units in the capture (6) plus the number of repeat units in the reporter (2) equals 8.
- the depiction relates to the diagram of Fig. 7A-7G in that it shows the results attained in the analysis of a DNA sample containing an eight repeat unit target with a two repeat unit reporter.
- Fig. 9A and Fig. 9B show diagrammatic views of a loopout embodiment of the invention.
- a capture 60 includes a first unique flanking sequence 62, a second unique flanking sequence 64 and an intervening sequence of repeat units 66 comprising one or more repeat units.
- a reporter 70 includes a reporter first unique flanking sequence 72, a reporter second unique flanking sequence 74 and an intervening sequence of repeat units 76.
- the number of repeat units in the intervening sequence of repeat units 76 of the reporter 70 may be the same as or different than the number of repeat units in the intervening sequence of repeat units 66 of the capture 60.
- a reporter label 78 may be included.
- Figs. 10A through 10G are depictions of multiplex systems having a variable length of repeat units. The numbering for Figs. 7-10 will adopt that from Figs. 9A and 9B to the extent practicable.
- a capture 60 includes a first unique flanking sequence 62, a second unique flanking sequence 64 and an intervening sequence of repeat units 66 having 5 repeat units.
- the reporter 70 includes a reporter first unique flanking sequence 72, a reporter second unique flanking sequence 74 and a intervening sequence of repeat units, specifically, 7 repeat units. A mismatch or loopout condition exists given the different number of repeat units in the intervening sequences 66, 76.
- Figs. 10A through 10G are depictions of multiplex systems having a variable length of repeat units. The numbering for Figs. 7-10 will adopt that from Figs. 9A and 9B to the extent practicable.
- a capture 60 includes a first unique flanking sequence 62, a second unique flanking sequence 64 and an intervening sequence of repeat units 66
- FIG. 10B and 10D- 10G a mismatch or loopout condition exists.
- Each of the component figures includes 7 base repeat units in the reporter 70.
- a flight or sequence of monitonically increasing number of repeat units in the intervening sequence of repeat units 66 for the capture 60 is depicted.
- Fig. 10B includes 6 repeat units, which still results with a mismatch, loopout condition in Fig. 10B where the excess repeat units in the intervening sequence 76 of the reporter 70 are looped out.
- the number or repeat units in the intervening sequence 66 in the capture 60 exceeds the number of repeat units in the intervening sequence 76 of the reporter.
- a loopout or mismatch condition then exists.
- the hybridization complex is labeled and the step of determining concordance and discordance includes detecting of the amounts of labeled hybridization complex at the test sites.
- the detection device and method may include, but is not limited to: optical imaging, electronic imaging, imaging with a CCD camera and integrated optical imaging. Further, the detection, either labeled or unlabeled, is quantified, which may include statistical analysis.
- the labeled portion of the complex may be the: target, capture, reporter or the hybridization complex in toto. Labeling may be by fluorescent labeling selected from the group of but not limited to: Bodipy Texas Red, Bodipy Far Red, Lucifer Yellow, Bodipy 630/650-X, Bodipy R6G-X and 5-CR 6G .
- Labeling may further be done by colormetric labeling, bioluminescent labeling and/or chemiluminescent labeling. Labeling further may include energy transfer between molecules in the hybridization complex by: perturbation analysis, quenching, electron transport between donor and acceptor molecules, the latter of which may be facilited by double stranded match hybridization complexes (See, e.g., Tom Meade and Faiz Kayyem, electron transport through DNA).
- detection may be accomplished by measurement of conductance differential between double stranded and non double stranded DNA (See, e.g., Tom Meade and Faiz Kayyem, electron transport through DNA).
- the label may be amplified, and may include for example branched or dendritic DNA.
- the target DNA may be unamplified or amplified.
- the purified target is amplified and the amplification is an exponential method, it my be, for example, PCR amplified DNA or SDA amplified DNA.
- Linear methods of DNA amplification such as rolling circle or transcriptional runoff may be used.
- target DNA is unpurified and unamplified or amplified, the amplification methods further consisting of PCR and SDA for exponential amplification and rolling circle or transcriptional runoff for linear amplification.
- the target DNA may be from a source of tissue including but not limited to: hair, blood, skin, sputum fecal matter, semen, epithelial cells, endothelial cells, lymphocytes, red blood cells, crime scene evidence.
- the source oftarget DNA may include: normal tissue, diseased tissue, tumor tissue, plant material, animal material, mammals, humans, birds, fish, microbial material, xenobiotic material, viral material, bacterial material, and protozoan material.
- the target material is from cloned organisms (Ian Wilmut, Roslyn Institute, Edinborough) to determine degree of identity and level of genetic drift.
- the source of the target material may include RNA.
- the source of the target material may include mitochondrial DNA.
- the THOl locus contains the tetranucleotide repeat (AATG) present in five to eleven copy-numbers in a noncoding region of the Human Tyrosine Hydroxylase gene (ref). This locus is one of many commonly used and accepted by the forensics community for DNA fingerprinting.
- Figure 1 depicts data from an experiment designed to determine the identities of the alleles present in an unknown target DNA sample after analysis by the method described here.
- a silicon chip was prepared by spin coating onto the top of the electrodes an organic layer of agarose mixed with streptavidin, thus forming the permeation layer that serves as the underlying foundation for DNA attachment (See e.g., U.S. Application Serial No. 08/271,882, filed July 7, 1994, entitled "Methods for Electronic Stringency Control for Molecular
- Pads were biased positive 5 at a time and a current source of + 4.0 microamps ( A) was applied for 38 milliseconds (ms). The polarity of the field was then reversed and - 4.0 A was applied to the 5 pads for 25 ms. This cycle was repeated 500 times for a total electronic addressing time of -30 seconds. Under these conditions, the biotin moiety of the capture oligo reacts with the streptavidin in the permeation layer over the activated test site to immobilize the capture oligo at that site.
- the electronic hybridization was done in low conductivity zwitterionic buffer at a temperature empirically determined to promote nonslippage hybridization. Due to the nature of electronic hybridization, specifically the low conductivity buffer (Edman, et al., Nucleic Acids Research, 1997), high stringency hybridization can be attained at lower temperatures than conventional nonelectronic hybridization. Experiments for THOl analysis were usually performed at 34- 42% C.
- the target DNA was electronically hybridized in 50 mM histidine buffer at its natural pH -5.4, at a concentration of 5-125 nM.
- the programmed electronic protocol included the following steps.
- Pads were biased positive 5 at a time and a current source of + 4.0 microamps ( A) was applied for 19 milliseconds (ms). The polarity of the field was then reversed and - 4.0 A was applied to the same 5 pads for 12 ms. This biased-AC cycle was repeated 500 times for a total electronic addressing time of ⁇ 30 seconds.
- the stringency of this hybridization step is critical due to the malleable nature of the tetranucleotide repeat complementary alignment. It is quite easy to obtain stable hybrids without aligning the flanking unique sequences, since the length of the repeat region is 20-44 bases. The out of register hybrids formed by insufficient stringency will not be accurately distinguished by any hybridization assay. High stringency hybridization can be attained at relatively low temperatures with electronic hybridization because of the low conductivity of the buffer and resulting low shielding of the repulsive negative charges on the DNA backbone. Electronic concentration of DNA overcomes these repulsive effects while maintaining highly stringent hybridization conditions.
- Reporter hybridization was most stable at those test sites where the target directs hybridization to provide a juxtaposition of the terminal nucleotides of the capture and reporter oligo. This additional stability is due to the base stacking of the terminal nucleotides. This juxtaposition will be 5'-3' or 3'-5' depending on the position of the attachment chemistry on the capture oligo. Unstable configurations would be a four base (or greater) gap between the capture and reporter or a four base (or greater) overlap of the capture and reporter ( See, e.g., Figs. 3A-3C, and 5A-5G).
- the DNA loaded chip is washed several times with 50 mM NaPO 4 , pH 7.0 at ambient temperature. The temperature of the hybridized organo-chip is then increased to 30% C and fluorescence levels at each test site are recorded at one minute time intervals. The fluorescent values are digitized by a computer program (IP Lab) as mean pixel intensity. A specific area over each pad is selected, and the pixel intensity for each site is stored for analysis. The histogram in Figure 1 displays the mean pixel intensity at each test site immediately after the denaturation step is complete.
- Fig. 11 shows a graph of the fluorescence as a function of number of repeat units.
- Example 2 Reanalysis of Target DNA with Redundant Reporters
- One Repeat Unit reporter was denatured from the match sites of the chip described in the preceding example by increasing the temperature -50% C, conditions which do not denature the target from the capture.
- This chip was then rehybridized with the Zero Repeat Unit reporter ( See, e.g., Fig. 5). This shifts the position of stable sandwich complexes from the 4 and 5 sites (See, Figure 12, left hand side, One Repeat Unit Reporter) to the 5 and 6 sites ( Figure 12, right hand side, Zero Repeat Unit Reporter).
- the target DNA in this case had a heterozygous mix of the 5 and 6 alleles of THOl.
- the reanalysis confirms the identity of the alleles present in the target DNA with a second oligo sequence.
- This redundant analysis increases the significance of the assay result since it is essentially a new interrogation of the target DNA with an oligo that has a different sequence.
- Using a different sequence reduces the possibility of artifactual results due to oligo secondary structure or other sequence-related anomalies. Therefore, the use of additional oligos for target analysis reduces the possibility of false positive and/or negative results.
- Base stacking is dependent on the interactions of the ring structure of one base with the base ring of its nearest neighbor. The strength of this interaction depends on the type of rings involved, as determined empirically. While applicants do not wish to be bound by any theory, among the possible theoretical explanations for this phenemon are the number electrons available between the two bases to participate in pi bond interactions and the efficiency of different base combinations to exclude water from the interior of the helix, thereby increasing entropy, Although the above models are consistent with current data, the possible mechanisms of stacking interactions are not limited to these concepts.
- Example 1 The experiment was done by the method described in Example 1 , with the exception that the locus examined was CSF1PO.
- CSF1PO CSF1PO capture and reporter were designed to change the terminal nucleotides from T-A to G-A.
- Figure 15 compares discrimination of match from mismatch hybrids containing either A-T or G-A terminal nucleotides. The results are displayed as discrimination ratios, that is the Mean Fluorescent Intensity (MFI) of the concordant site divided by the average MFI of the discordant sites.
- MFI Mean Fluorescent Intensity
- the TPOX locus contains the tetranucleotide repeat (AATG) present in six to thirteen copy-numbers in a noncoding region of the Human Thyroid Peroxidase gene (See, e.g., Anbach et al., 1996, Advanced in Forensic Haemogenetics). This locus is also one of many commonly used and accepted by the forensics community for DNA fingerprinting. The sequences are provided in Fig. 17.
- Figure 16 depicts data from an experiment where target DNA containing the TPOX 8 and 11 alleles was analyzed by a procedure nearly identical to that described in Example 1. Oligo capture DNA containing all allelic possibilities was electronically addressed to individual sites on the chip. A mix of complementary target DNA, composed of TPOX alleles with 8 and 11 STRs, was then electronically hybridized to each of the pads containing addressed capture DNA. The conditions for electronic hybridization were the same as those outlined in Example 1. One Repeat Unit Reporter oligo was then passively hybridized to the array and treated in the manner of the THOl example. Figure 16 shows a stable hybridization complex at the test sites containing capture oligos with 7 and 10 repeat units. Since the reporter oligo has one repeat unit, the target DNA can be identified as having 8 and 11 repeat units.
- Example 5 Hybridization discrimination of CSF1PO alleles
- Capture oligos containing CSF1PO alleles 7 through 15 (Fig. 19) inclusive were electronically addressed to representative sites as previously described.
- Target DNA containing CSF1PO 11 and 12 alleles (Fig. 19) was then electronically hybridized to each of the sites.
- the CSF1PO one repeat unit reporter ( Fig. 19) was then. Denaturation of the reporter was done at 30% C.
- Figure 18 shows the mean pixel intensity at various capture sites after the assay, demonstrating the ability of the assay to correctly discriminate the alleles present in the target sample. The experiment was done as described in Example 1.
- Example 6 THO 1/TPOX Multiplex Analysis
- Locus-allele specific capture oligos were individually addressed to different sites on a single chip.
- the DNA chip containing capture oligos was then hybridized with a mixture of THOl and TPOX target DNA containing heterozygote alleles.
- the chip was then washed and analyzed by the hybridization assay of the form described previously. The above steps were performed as described in Example 1. Relative fluorescent levels were used to determine whether sites contain concordant or discordant DNA hybrid complexes. Both reporters used contained one repeat unit.
- Fig. 20 showed that under the assay conditions, 7 and 9 STR alleles of THOl hybridized very well with their cognitive capture sites. Hybridization to other capture alleles was not detectable (5x, 7x, 9x and lOx), indicating an excellent discrimination of THOl 7/9 heterozygote. For the TPOX locus, we also obtained a good matched capture/target interaction (sites 9x and 1 lx).
- the stability of the discordant hybridization complexes formed with the 10 and 12 STR targets was so low that the complexes were either undetectable (7xc and 12xc), or low enough to yield a discrimination ratio of 15 fold or higher (lOxc and 8xc respectively), resulting in easy discrimination of TPOX 10/12 heterozygote target.
- Example 7 Identification of STR Alleles in Double Stranded PCR-amplified DNA This experiment was done to determine the utility of the current invention as applied to interrogation of double-stranded DNA generated by PCR amplification.
- Figure 6 provides an example of the ability of our system to accurately identify PCR generated targets.
- the TPOX 1 locus was PCR amplified using a genomic template from the K562 cell line following standard conditions outlined in the Promega STR User's manual (3).
- the genotype ofK562 is heterozygous for the 8 and 9 repeat alleles.
- the amplicon was denatured at 95% C and hybridized to a Nanogen APEX chip.
- the chip had capture probes unique for PCR products containing each number of repeat length.
- Figure 21 shows the relative amount of signal present on the positive (8C, 9C match) and negative (7C, IOC mismatch) after the experiment has been performed.
- detection has been accomplished by direct fluorescent labeling of the reporter or reporter/target DNA.
- One embodiment would be fluorescence perturbation where quencher and reporter chromophores are positioned proximal to each other such that fluorescence is quenched. See, e.g., (Methods for Hybridization Analysis Utilizing Electrically Controlled Hybridization and Methods For Electronic Fluorescent Perturbation for Analysis and Electronic Perturbation Catalysis for Synthesis), all incorporated by reference as if fully set forth herein. Oligo synthesis and conjugation methods and materials are commonly practiced.
- the capture probe would have attachment moiety, such as biotin, at one end and a chromophore at the distal terminus or the terminus which extends into the STR region.
- attachment moiety such as biotin
- linker arms or spacers would be incorporated at the appropriate location internally or at the terminus. These linker arms would have a functional group to which chromophores could later be conjugated, such as amino linker and succinimidyl ester chromophore.
- the reporter probe would have a different chromophore incorporated in the same manner, at the end which extends into the STR region. Thus, in the presence of target the capture and reporter probes would hybridize and position the chromophores proximal to one another.
- Example 9 Target -Dependent Ligation of Capture and Reporter An additional embodiment of this invention would be to further stabilize the attachment- of the reporter to the concordant test site by ligating the reporter to the preattached capture.
- the critical part of this embodiment would be to accomplish the ligation in a selective manner, maintaining the ability to discriminate match from mismatch hybrids. This could be done by careful maintenance of hybridization stringency, by electronic or conventional methods.
- Ligation could be achieved enzymatic (Maniatis et al., Molecular Cloning, a Laboratory Manual, 1982) or chemical methods (Gryaznov, Nucleic Acids Research, 1994). Selection of the method could be determined by the kinetics involved with the specific type of reaction as well as the overall efficiency of taking a particular method into a product.
- Example 10 Discriminating Match from Mismatch/Gap and Mismatch/Overlap
- Figs. 22A, 22B and 22C show graphics of fluorescence intensity for a gap, match and overlap condition (bar charts from left to right), for the initial signal (Fig. 22A) after three minutes of denaturation (Fig. 22B) and after ten minutes of denaturation (Fig. 22C).
- This feature of the technology provides additional information about the target DNA, that is, information regarding all three types of possible hybrids. This additional information can be used in several ways.
- Fig. 23 shows the potential for this feature in use with the THO 1 locus. It predicts that correct identification of all THO 1 alleles can be achieved with a set of capture oligos which have five, seven and nine repeat units in combination with the one repeat unit reporter THOl locus. This reduces the required number of analytical test sites from seven to three. This feature, when combined with the ability to do redundant reporters, could greatly reduce the number of pads required for the analysis of a set of loci for statistically significant genotyping. Currently this level is approximately 10 loci.
- the beneficial effect of this would be to permit more loci on a single chip, and therefore with larger arrays, the ability to assay multiple individuals on the same chip thereby reducing - the cost of the assay. This would be especially useful for high throughput processing, as will be required for the STR databasing of felons currently under way.
- a different oligonucleotide system can be used.
- This method designated the loopout system, is outlined in Figure 9A and 9B, and Figs. 10A-10G. It is evident from the drawing that this is an alternative to the sandwich method of identifying alleles in a matrix.
- the loopout system uses an array of capture oligos which are distributed in a similar manner to the sandwich format. The structure of the capture oligos differs from ones in the sandwich format by the presence of locus-specific unique sequence flanking both ends of the repeat region.
- the target DNA is labeled and serves as the reporter molecule. The target can be labeled during amplification by using a PCR primer which is fluorescent (or contains any other suitable molecular adaptation for detection).
- loopout capture oligos which are specific to different alleles of a locus are arrayed in a matrix such that individual test sites represent different alleles (See, e.g., Figure 6). Actual test results are shown in Fig. 24. Labeled target oligo is then stringently hybridized under electronic conditions to the entire array. The test site with the most stable hybrids will be concordant with the allelic identity of the target DNA. Determining the position of the stable hybrids (and therefore the allele-specific capture oligo attached to it) identifies the alleles represent in the target DNA. Hybrids formed between capture and reporter oligos which have the same number of repeat units are matched.
- this test site is concordant with the identity of the target allele.
- Test sites which are discordant or contain an unequal number of repeat units between the capture and the target will form a hybrid with a loop in either the target or capture DNA (See, e.g., Figs. 10A, 10B and 10D-10G).
- Discordant sites which have captures with fewer repeat units than the target will yield hybrids with loops in the These hybrids will be inherently less stable than the match hybrids. Therefore denaturation by electronic stringency control will discriminate stable from less stable hybrids indicating the sites of concordancy, and based upon the knowledge of the probes present at those sites, enable the user to determine the number of repeat units in the target DNA.
- STR microvariant is the THOl 9.3 allele. It is important because it is present in a significant portion of the Caucasian population.
- the assay for the 9.3 microvariant was essentially the same as the normal STR alleles but required special capture and reporter oligo design.
- the capture oligo contains only three repeat units (3ru, Fig. 13).
- THOl 9.3 target DNA binding to the capture will be less stable at capture sites containing greater than three repeat units because there will be a frame-shift in the repeat region of 9.3.
- the reporter oligo (Microvar 9.3, Fig. 13) has been designed so that it will bind most stably to the repeat unit region containing the deletion. Additionally, the capture oligo has been designed so that target directed base stacking of the capture and reporter DNA will occur only at the 3ru test site.
- Figure 25 shows a detailed sequence alignment of the capture and reporter oligonucleotides used to detect the THOl 9.3 microvariant. The numbering in the drawing is consistent with that found in Figure 4C, with the addition of sequence 45 which is complementary to the partial repeat unit which constitutes the microvariant. This particular microvariant reporter has no second unique flanking sequence 42. This is necessary for analysis of THOl 9.3 allele not be a feature of other micro variant-specific reporters.
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69931608T DE69931608T2 (en) | 1998-02-25 | 1999-02-12 | METHOD FOR DETERMINING DNA LENGTH POLYMORPHISMS |
CA002322206A CA2322206A1 (en) | 1998-02-25 | 1999-02-12 | Methods and apparatus for determination of length polymorphisms in dna |
EP99908154A EP1056887B1 (en) | 1998-02-25 | 1999-02-12 | Methods for determination of length polymorphisms in dna |
AU27653/99A AU2765399A (en) | 1998-02-25 | 1999-02-12 | Methods and apparatus for determination of length polymorphisms in dna |
JP2000533592A JP2002519998A (en) | 1998-02-25 | 1999-02-12 | Method and apparatus for detecting sequence length polymorphisms in DNA |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/030,156 US6207373B1 (en) | 1998-02-25 | 1998-02-25 | Methods for determining nature of repeat units in DNA |
US09/030,156 | 1998-02-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999043853A1 WO1999043853A1 (en) | 1999-09-02 |
WO1999043853A9 true WO1999043853A9 (en) | 1999-11-11 |
Family
ID=21852807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/003175 WO1999043853A1 (en) | 1998-02-25 | 1999-02-12 | Methods and apparatus for determination of length polymorphisms in dna |
Country Status (9)
Country | Link |
---|---|
US (3) | US6207373B1 (en) |
EP (1) | EP1056887B1 (en) |
JP (1) | JP2002519998A (en) |
CN (1) | CN1252282C (en) |
AT (1) | ATE328114T1 (en) |
AU (1) | AU2765399A (en) |
CA (1) | CA2322206A1 (en) |
DE (1) | DE69931608T2 (en) |
WO (1) | WO1999043853A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9388457B2 (en) | 2007-09-14 | 2016-07-12 | Affymetrix, Inc. | Locus specific amplification using array probes |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994003624A1 (en) * | 1992-08-04 | 1994-02-17 | Auerbach Jeffrey I | Methods for the isothermal amplification of nucleic acid molecules |
US6261808B1 (en) * | 1992-08-04 | 2001-07-17 | Replicon, Inc. | Amplification of nucleic acid molecules via circular replicons |
US7582421B2 (en) * | 1993-11-01 | 2009-09-01 | Nanogen, Inc. | Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip |
US6468742B2 (en) | 1993-11-01 | 2002-10-22 | Nanogen, Inc. | Methods for determination of single nucleic acid polymorphisms using bioelectronic microchip |
US6207373B1 (en) * | 1998-02-25 | 2001-03-27 | Nanogen, Inc. | Methods for determining nature of repeat units in DNA |
US6379897B1 (en) | 2000-11-09 | 2002-04-30 | Nanogen, Inc. | Methods for gene expression monitoring on electronic microarrays |
US6207673B1 (en) * | 1997-03-12 | 2001-03-27 | The University Of North Carolina At Chapel Hill | Covalent conjugates of topoisomerase I and topoisomerase II inhibitors |
US6013459A (en) | 1997-06-12 | 2000-01-11 | Clinical Micro Sensors, Inc. | Detection of analytes using reorganization energy |
AU2144000A (en) | 1998-10-27 | 2000-05-15 | Affymetrix, Inc. | Complexity management and analysis of genomic dna |
CA2372909A1 (en) * | 1999-03-30 | 2000-10-05 | Nanogen, Inc. | Single nucleotide polymorphic discrimination by electronic dot blot assay on semiconductor microchips |
AU769929B2 (en) * | 1999-04-12 | 2004-02-12 | Nanogen, Inc. | Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip |
US6958225B2 (en) | 1999-10-27 | 2005-10-25 | Affymetrix, Inc. | Complexity management of genomic DNA |
US6642046B1 (en) * | 1999-12-09 | 2003-11-04 | Motorola, Inc. | Method and apparatus for performing biological reactions on a substrate surface |
US6824669B1 (en) | 2000-02-17 | 2004-11-30 | Motorola, Inc. | Protein and peptide sensors using electrical detection methods |
US6602400B1 (en) | 2000-06-15 | 2003-08-05 | Motorola, Inc. | Method for enhanced bio-conjugation events |
KR100443569B1 (en) * | 2000-12-15 | 2004-08-09 | 학교법인 인하학원 | Method of personal identification and paternity testing by optimizing conditions of multiplex PCR using length-polymorphic DNA sequence |
DE10122659A1 (en) * | 2001-05-10 | 2002-12-05 | Infineon Technologies Ag | Biochip arrangement |
US6893822B2 (en) | 2001-07-19 | 2005-05-17 | Nanogen Recognomics Gmbh | Enzymatic modification of a nucleic acid-synthetic binding unit conjugate |
CA2460759C (en) | 2001-09-24 | 2011-05-31 | One Lambda | Diagnostic probe detection system |
AU2011253686C1 (en) * | 2001-09-28 | 2014-04-03 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. | Micro-RNA molecules |
EP2390329B1 (en) | 2001-09-28 | 2018-04-18 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | MicroRNA molecules |
US20030175947A1 (en) * | 2001-11-05 | 2003-09-18 | Liu Robin Hui | Enhanced mixing in microfluidic devices |
GB0205455D0 (en) | 2002-03-07 | 2002-04-24 | Molecular Sensing Plc | Nucleic acid probes, their synthesis and use |
US20040011650A1 (en) * | 2002-07-22 | 2004-01-22 | Frederic Zenhausern | Method and apparatus for manipulating polarizable analytes via dielectrophoresis |
US7601493B2 (en) * | 2002-07-26 | 2009-10-13 | Nanogen, Inc. | Methods and apparatus for screening and detecting multiple genetic mutations |
WO2004016767A2 (en) * | 2002-08-19 | 2004-02-26 | The President And Fellows Of Harvard College | Evolving new molecular function |
US7270952B2 (en) * | 2002-09-24 | 2007-09-18 | Intel Corporation | Detecting molecular binding by monitoring feedback controlled cantilever deflections |
US7125672B2 (en) * | 2003-05-07 | 2006-10-24 | E. I. Du Pont De Nemours And Company | Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts |
WO2005030929A2 (en) * | 2003-09-23 | 2005-04-07 | Atom Sciences, Inc. | Polymeric nucleic acid hybridization probes |
US20060008823A1 (en) * | 2004-05-12 | 2006-01-12 | Kemp Jennifer T | DNA profiling and SNP detection utilizing microarrays |
WO2007044071A2 (en) * | 2005-04-21 | 2007-04-19 | Exact Sciences Corporation | Analysis of heterogeneous nucleic acid samples |
US20070020671A1 (en) * | 2005-07-12 | 2007-01-25 | Radtkey Ray R | Method for detecting large mutations and duplications using control amplification comparisons to paralogous genes |
CA2703227C (en) * | 2007-10-22 | 2017-02-28 | Lgc Limited | Oligonucleotides and uses thereof |
US9074244B2 (en) | 2008-03-11 | 2015-07-07 | Affymetrix, Inc. | Array-based translocation and rearrangement assays |
US20130183666A1 (en) | 2012-01-18 | 2013-07-18 | Marc N. Feiglin | Partial genotyping by differential hybridization |
US20150240297A1 (en) * | 2012-07-31 | 2015-08-27 | Juan Carlos Jaime | Method for obtaining and detecting a marker of objects to be identified, related marker, authentication method and verification method |
JP2023516362A (en) * | 2020-03-03 | 2023-04-19 | ユニベルシテイト ゲント | Hydrolysis-based probes and methods for determining STR genotypes |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
EP0317239A3 (en) | 1987-11-13 | 1990-01-17 | Native Plants Incorporated | Method and device for improved restriction fragment length polymorphism analysis |
US4963663A (en) | 1988-12-23 | 1990-10-16 | University Of Utah | Genetic identification employing DNA probes of variable number tandem repeat loci |
DE3834636A1 (en) | 1988-10-11 | 1990-04-19 | Max Planck Gesellschaft | METHOD FOR ANALYZING LENGTH POLYMORPHISMS IN DNA AREAS |
GB8824531D0 (en) | 1988-10-20 | 1988-11-23 | Ici Plc | Polynucleotide probes |
GB2228086A (en) | 1988-11-25 | 1990-08-15 | Ici Plc | Characterisation of genomic DNA |
US5364759B2 (en) | 1991-01-31 | 1999-07-20 | Baylor College Medicine | Dna typing with short tandem repeat polymorphisms and identification of polymorphic short tandem repeats |
US6048690A (en) * | 1991-11-07 | 2000-04-11 | Nanogen, Inc. | Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis |
US6017696A (en) * | 1993-11-01 | 2000-01-25 | Nanogen, Inc. | Methods for electronic stringency control for molecular biological analysis and diagnostics |
US5605662A (en) * | 1993-11-01 | 1997-02-25 | Nanogen, Inc. | Active programmable electronic devices for molecular biological analysis and diagnostics |
US5849486A (en) * | 1993-11-01 | 1998-12-15 | Nanogen, Inc. | Methods for hybridization analysis utilizing electrically controlled hybridization |
US5632957A (en) | 1993-11-01 | 1997-05-27 | Nanogen | Molecular biological diagnostic systems including electrodes |
US6051380A (en) * | 1993-11-01 | 2000-04-18 | Nanogen, Inc. | Methods and procedures for molecular biological analysis and diagnostics |
US5403708A (en) | 1992-07-06 | 1995-04-04 | Brennan; Thomas M. | Methods and compositions for determining the sequence of nucleic acids |
AU6031094A (en) * | 1993-01-15 | 1994-08-15 | Public Health Research Institute Of The City Of New York, Inc., The | Sensitive nucleic acid sandwich hybridization assays and kits |
US6207373B1 (en) * | 1998-02-25 | 2001-03-27 | Nanogen, Inc. | Methods for determining nature of repeat units in DNA |
EP0758403B1 (en) | 1994-05-05 | 1998-06-24 | Beckman Instruments, Inc. | Oligonucleotide repeat arrays |
US5795716A (en) * | 1994-10-21 | 1998-08-18 | Chee; Mark S. | Computer-aided visualization and analysis system for sequence evaluation |
GB9507238D0 (en) * | 1995-04-07 | 1995-05-31 | Isis Innovation | Detecting dna sequence variations |
US5753439A (en) * | 1995-05-19 | 1998-05-19 | Trustees Of Boston University | Nucleic acid detection methods |
US5908745A (en) | 1996-01-16 | 1999-06-01 | University Of Chicago | Use of continuous/contiguous stacking hybridization as a diagnostic tool |
US6090549A (en) | 1996-01-16 | 2000-07-18 | University Of Chicago | Use of continuous/contiguous stacking hybridization as a diagnostic tool |
JP3898228B2 (en) * | 1996-04-12 | 2007-03-28 | ザ パブリック ヘルス リサーチ インスティチュート オブ ザ シティー オブ ニューヨーク インク | Detection probes, kits and assays |
US5881269A (en) | 1996-09-30 | 1999-03-09 | International Business Machines Corporation | Simulation of multiple local area network clients on a single workstation |
-
1998
- 1998-02-25 US US09/030,156 patent/US6207373B1/en not_active Expired - Lifetime
-
1999
- 1999-02-12 AT AT99908154T patent/ATE328114T1/en not_active IP Right Cessation
- 1999-02-12 DE DE69931608T patent/DE69931608T2/en not_active Expired - Lifetime
- 1999-02-12 JP JP2000533592A patent/JP2002519998A/en active Pending
- 1999-02-12 WO PCT/US1999/003175 patent/WO1999043853A1/en active IP Right Grant
- 1999-02-12 EP EP99908154A patent/EP1056887B1/en not_active Expired - Lifetime
- 1999-02-12 AU AU27653/99A patent/AU2765399A/en not_active Abandoned
- 1999-02-12 CA CA002322206A patent/CA2322206A1/en not_active Abandoned
- 1999-02-12 CN CNB998052078A patent/CN1252282C/en not_active Expired - Fee Related
-
2000
- 2000-08-24 US US09/645,757 patent/US6395493B1/en not_active Expired - Lifetime
-
2002
- 2002-03-25 US US10/108,280 patent/US6753148B2/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9388457B2 (en) | 2007-09-14 | 2016-07-12 | Affymetrix, Inc. | Locus specific amplification using array probes |
Also Published As
Publication number | Publication date |
---|---|
JP2002519998A (en) | 2002-07-09 |
CN1297489A (en) | 2001-05-30 |
DE69931608T2 (en) | 2007-05-16 |
US6753148B2 (en) | 2004-06-22 |
EP1056887B1 (en) | 2006-05-31 |
ATE328114T1 (en) | 2006-06-15 |
EP1056887A4 (en) | 2002-08-28 |
WO1999043853A1 (en) | 1999-09-02 |
US6207373B1 (en) | 2001-03-27 |
CN1252282C (en) | 2006-04-19 |
CA2322206A1 (en) | 1999-09-02 |
DE69931608D1 (en) | 2006-07-06 |
EP1056887A1 (en) | 2000-12-06 |
AU2765399A (en) | 1999-09-15 |
US6395493B1 (en) | 2002-05-28 |
US20020115098A1 (en) | 2002-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1056887B1 (en) | Methods for determination of length polymorphisms in dna | |
US6468742B2 (en) | Methods for determination of single nucleic acid polymorphisms using bioelectronic microchip | |
US9340834B2 (en) | Method of designing addressable array suitable for detection of nucleic acid sequence differences using ligase detection reaction | |
US6027880A (en) | Arrays of nucleic acid probes and methods of using the same for detecting cystic fibrosis | |
US20020187477A1 (en) | Method for detecting single nucleotide polymorphisms (SNPs) and point mutations | |
US20050266417A1 (en) | Methods for identifying target nucleic acid molecules | |
CA2899287A1 (en) | Optimization of gene expression analysis using immobilized capture probes | |
WO1998051819A9 (en) | Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis | |
KR20000075555A (en) | Gene sequencer and methods | |
Liu et al. | A surface-based approach to DNA computation. | |
AU776421B2 (en) | Method for the controlled implementation of complex PCR amplifications | |
AU742599B2 (en) | Multiple functionalities within an array element and uses thereof | |
US7582421B2 (en) | Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip | |
AU769929B2 (en) | Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip | |
WO2003002752A2 (en) | Methods of using nick translate libraries for snp analysis | |
Best et al. | Molecular pathology methods | |
CN114929896A (en) | Efficient methods and compositions for multiplex target amplification PCR | |
WO2001073122A1 (en) | Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip | |
WO2003070977A2 (en) | Method for detecting single nucleotide polymorphisms | |
IL145880A (en) | Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip | |
US20120329677A9 (en) | Arrays of nucleic acid probes for detecting cystic fibrosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99805207.8 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BR CA CN JP KR NZ |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AU BR CA CN JP KR NZ |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/27-27/27, DRAWINGS, REPLACED BY NEW PAGES 1/21-21/21; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1999908154 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2322206 Country of ref document: CA Ref document number: 2322206 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 27653/99 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2000 533592 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1999908154 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1999908154 Country of ref document: EP |